心血管疾病一级预防的新视野，我们能否通过“心脏复方制剂”预防心脏病发作？ - Suppr

A new horizon in primary prevention of cardiovascular disease, can we prevent heart attack by "heart polypill"?

作者信息

Rastegarpanah Mansoor, Malekzadeh Fatemeh, Thomas G Neil, Mohagheghi Abbas, Cheng K K, Marshall Tom

机构信息

Digestive Disease Research Center, Medical Science/University of Tehran, Shariati Hospital, Kargar Shomali Ave, Tehran, Iran.

出版信息

Arch Iran Med. 2008 May;11(3):306-13.

PMID:18426322

Abstract

摘要

相似文献

A new horizon in primary prevention of cardiovascular disease, can we prevent heart attack by "heart polypill"?

Arch Iran Med. 2008 May;11(3):306-13.

Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients.

Am J Med. 2012 Sep;125(9):882-7.e1. doi: 10.1016/j.amjmed.2011.12.013. Epub 2012 Jun 27.

Ask the doctor. I had a heart attack three years ago at age 78. My doctor started me on lisinopril, carvedilol, and aspirin. My total cholesterol is 190, and my LDL is 128. Should I be taking a statin?

Harv Heart Lett. 2011 Aug;21(12):7.

Polypill in cardiovascular disease: has it's time come?

Indian Heart J. 2009 Jul-Aug;61(4):322-7.

Primary prevention of myocardial infarction: putting the evidence to use.

Arch Intern Med. 2010 Aug 9;170(15):1381-2. doi: 10.1001/archinternmed.2010.266.

The Polypill in the prevention of cardiovascular disease.

Prev Med. 2011 Jan;52(1):16-7. doi: 10.1016/j.ypmed.2010.11.015. Epub 2010 Dec 2.

Adding ACE inhibitors or ARBs to standard therapy for stable ischemic heart disease.

Am Fam Physician. 2012 Jul 1;86(1):21-3.

Re: Secondary medical prevention in patients with peripheral arterial disease.

Eur J Vasc Endovasc Surg. 2008 Jan;35(1):59-60. doi: 10.1016/j.ejvs.2007.07.006. Epub 2007 Aug 27.

[The polypill: optimal strategy for reduction of cardiovascular disease].

Ned Tijdschr Geneeskd. 2005 Jul 30;149(31):1740.

Drug secondary prevention in postmenopausal women with ischemic heart disease.

Rom J Intern Med. 2009;47(1):41-5.

引用本文的文献

The clinical performance of an office-based risk scoring system for fatal cardiovascular diseases in North-East of Iran.

PLoS One. 2015 May 26;10(5):e0126779. doi: 10.1371/journal.pone.0126779. eCollection 2015.

Cardiovascular disease mortality and years of life lost attributable to non-optimal systolic blood pressure and hypertension in northeastern Iran.

Arch Iran Med. 2015 Mar;18(3):144-52.

Polypill for the prevention of cardiovascular disease (PolyIran): study design and rationale for a pragmatic cluster randomized controlled trial.

Eur J Prev Cardiol. 2015 Dec;22(12):1609-17. doi: 10.1177/2047487314550803. Epub 2014 Sep 17.

Polypill therapy, subclinical atherosclerosis, and cardiovascular events-implications for the use of preventive pharmacotherapy: MESA (Multi-Ethnic Study of Atherosclerosis).

J Am Coll Cardiol. 2014 Feb 11;63(5):434-43. doi: 10.1016/j.jacc.2013.08.1640. Epub 2013 Oct 23.

The gastro-esophageal malignancies in Northern Iran research project: impact on the health research and health care systems in Iran.

Arch Iran Med. 2013 Jan;16(1):46-53.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

A new horizon in primary prevention of cardiovascular disease, can we prevent heart attack by "heart polypill"?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

A new horizon in primary prevention of cardiovascular disease, can we prevent heart attack by "heart polypill"?

作者信息

机构信息

出版信息

相似文献

引用本文的文献